Next Article in Journal
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines
Next Article in Special Issue
Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations
Previous Article in Journal
Aberrant DNA Methylation of NPTX2 as an Indicator of Malignant Behavior in Thymic Epithelial Tumors
 
 
Article

Article Versions Notes

Cancers 2024, 16(2), 333; https://doi.org/10.3390/cancers16020333
Action Date Notes Link
article xml file uploaded 12 January 2024 04:54 CET Original file -
article xml uploaded. 12 January 2024 04:54 CET Update -
article pdf uploaded. 12 January 2024 04:54 CET Version of Record https://www.mdpi.com/2072-6694/16/2/333/pdf-vor
article supplementary file uploaded. 12 January 2024 04:54 CET - https://www.mdpi.com/2072-6694/16/2/333#supplementary
article html file updated 12 January 2024 04:56 CET Original file -
article xml file uploaded 16 January 2024 04:34 CET Update -
article xml uploaded. 16 January 2024 04:34 CET Update https://www.mdpi.com/2072-6694/16/2/333/xml
article pdf uploaded. 16 January 2024 04:34 CET Updated version of record https://www.mdpi.com/2072-6694/16/2/333/pdf
article html file updated 16 January 2024 04:37 CET Update https://www.mdpi.com/2072-6694/16/2/333/html
Back to TopTop